Cardlytics, Inc. — Director's Dealing 2020

Jul 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2020-07-16

Reporting Person: Christiansen Andrew (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-16	Common Stock	M	4707	$24.48	Acquired	15420	Direct
2020-07-16	Common Stock	S	4707	$79	Disposed	10713	Direct
2020-07-20	Common Stock	M	2518	$24.48	Acquired	13231	Direct
2020-07-20	Common Stock	S	2518	$79	Disposed	10713	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-16	Employee Stock Option (Right to Buy)	$24.48	M	4707	Disposed	2027-04-01	Common Stock (4707.0)	Direct
2020-07-20	Employee Stock Option (Right to Buy)	$24.48	M	2518	Disposed	2027-04-01	Common Stock (2518.0)	Direct

Footnotes

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2020.

F2: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.